An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

On the latest episode of the science talk show GEN Live, I was joined by a pair of experts to discuss the state of ...

The funds will support ongoing work on Fulcrum, Pairwise's gene-editing platform and efforts to create edited crops with specific traits.

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

Researchers investigated RA51C and uncovered over 3,000 harmful genetic changes that could increase cancer risk.

A new bioprocessing technique developed by a team of researchers could improve a range of therapies based on CAR-T cells.

A primary drying process model that includes the various sources of process variability can guide the process optimization ...